https://www.selleckchem.com/pr....oducts/gsk-j4-hcl.ht
The use of atosiban for tocolysis does not improve the rate of successful ECVs when compared to beta-agonists. However, atosiban was associated with a significantly lower incidence of side effects and comparable cesarean section rates. The use of atosiban for tocolysis does not improve the rate of successful ECVs when compared to beta-agonists. However, atosiban was associated with a significantly lower incidence of side effects and comparable cesarean section rates. To examine the association between vaginal delivery of a previous m
Like
Comment
Share
